🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

The Lymphocytic Infiltrate of Lung Tumors.

Recruitingn/aAges 18 Years - anyAllScientific Institute San Raffaele
NCT06470607 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The study is configured as a monocentric observational transversal biological study. The main objective of the study is the reconstruction of the molecular organization of tumors of the thoracic cavity, in particular non-small cell lung cancer (NSCLC). The study involves the collection of clinical data and biological material (blood and tumor tissue) from 70 subjects diagnosed with thoracic tumors.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Ability to provide informed consent; * Men and women over the age of 18; * Patients candidates for surgical treatment diagnosed with thoracic tumors Exclusion Criteria: * Previous chemotherapy for any cancer within the last 6 months; * Pregnant and/or breastfeeding women; * Immunosuppressive state (states of immunosuppression or ongoing immunosuppressive/immunomodulatory treatments)
💊

What it tests

  • Not listed
📍

Where

1 site
Scientific Institute Ospedale San Raffaele
Milan, Italy
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy